March 17 - 18, 2015
Hyatt Regency Airport
Burlingame, CA
Health Economics and Research Strategies to Drive Market Access
Event Website: Click here
In the medical device market, payers at all levels are looking at the costs and benefits to justify investment in new medical technologies and the new procedures in which they might be used. Globally, payers are assessing technologies on the grounds of clinical effectiveness, cost effectiveness, cost utility and cost benefit. As the industry moves towards HTA and value demonstration as a requirement for medical devices, value demonstration will increasingly be a fact that all medical device companies seeking to gain reimbursement and approval from payers and regulatory bodies need to take into consideration. This conference walks stakeholders through what payers are looking for, as well as strategies to better achieve device and diagnostic reimbursement and approval.
PMC members shape and advance the future of personalized medicine.
Join Today